News, Analysis & Insights on Nutrition, Supplements, and Health
Only about 25 per cent of women in many countries voluntarily take folic acid tablets before conception, say Australian researchers, despite evidence to show that adequate levels of the nutrient could halve the risk of neural tube defects in offspring.
Swiss marketing group DKSH introduced a new fibre to the European market last week, which could steal sales of the increasingly popular ingredient inulin.
New research appears to lend weight to the theory that rapid growth in infancy, boosted by enriched infant formulas, might increase the risk of heart disease and stroke later in life, say UK-based scientists.
Swiss chemicals group Lonza has launched a slow release niacin that almost eliminates the skin flushing commonly seen with the standard vitamin.
Spanish company Natraceutical has developed a range of products that can be sold directly to the consumer in a bid to kickstart sales of a line inspired by the Mediterranean diet. It includes a plant extract to rival the popular supplement saw palmetto.
British researchers have created a vegetable with high levels of healthy fatty acids, normally found only in fish and poultry products.
Israeli flavours and ingredients group Frutarom benefited from the recent merger with Swiss counterpart Flachsmann to post a 55 per cent increase in first quarter sales. Growth in the functional foods sector also contributed to the strong Q1 growth.
Chemi Nutra has gained exclusive rights to a new patent on its soy-derived phosphatidylserine product relating to its ability to suppress cortisol, a catabolic stress hormone that can inhibit the use of protein by muscles and impair recovery.
New research appears to lend weight to the theory that rapid growth in infancy, boosted by enriched infant formulas, might increase the risk of heart disease and stroke later in life, say UK-based scientists.
Coca producers in Peru are creating a new application for the plant in energy drinks and health foods, steering their industry away from the drugs trade, according to a report.
Food and supplement makers seeking entry to the rapidly growing low-carb market may not need to reformulate or develop new products, according to a market researcher.